Status:
RECRUITING
Comparison of FDG and FAPI in Patients With Various Types of Cancer
Lead Sponsor:
The First Affiliated Hospital of Xiamen University
Conditions:
Tumor, Solid
Positron-Emission Tomography
Eligibility:
All Genders
18-90 years
Phase:
NA
Brief Summary
To evaluate the potential usefulness of 68Ga-DOTA-FAPI-04 positron emission tomography/computed tomography (PET/CT) for the diagnosis of primary and metastatic lesions in various types of cancer, comp...
Detailed Description
Subjects with various types of cancer underwent contemporaneous 68Ga-DOTA-FAPI-04 and 18F-FDG PET/CT either for an initial assessment or for recurrence detection. Tumor uptake was quantified by the ma...
Eligibility Criteria
Inclusion
- (i) adult patients (aged 18 years or order); (ii) patients with suspected or newly diagnosed or previously treated malignant tumors (supporting evidence may include magnetic resonance imaging (MRI), CT, tumor markers and pathology report); (iii) patients who had scheduled both 18F-FDG and 68Ga-DOTA-FAPI-04 PET/CT scans; (iv) patients who were able to provide informed consent (signed by participant, parent or legal representative) and assent according to the guidelines of the Clinical Research Ethics Committee.
Exclusion
- (i) patients with non-malignant lesions; (ii) patients with pregnancy; (iii) the inability or unwillingness of the research participant, parent or legal representative to provide written informed consent.
Key Trial Info
Start Date :
October 20 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 30 2027
Estimated Enrollment :
3000 Patients enrolled
Trial Details
Trial ID
NCT04416165
Start Date
October 20 2019
End Date
December 30 2027
Last Update
August 8 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
First affiliated hospital of xiamen university
Xiamen, Fujian, China, 0086-361000